EECP Therapy Increased Exercise Duration and Quality of Life In Congestive Heart Failure Patients 體外反搏治療顯著提升慢性心臟衰竭患者的 運動持續時間

Source From 資料來源 : https://onlinelibrary.wiley.com/doi/full/10.1111/j.1527-5299.2006.05904.x?sid=nlm%3Apubmed

EECP Therapy Increased Exercise Duration and Quality of Life In Congestive Heart Failure Patients

The Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) trial demonstrated that enhanced external counterpulsation (EECP) therapy increased exercise duration and improved functional status and quality of life without affecting peak oxygen consumption. The authors present data from a prespecified subgroup of elderly patients (65 years or older) enrolled in the PEECH trial. The 2 co-primary end points were the percentage of subjects with a >60-second increase in exercise duration and the percentage of subjects with a >1.25-mL/kg/min increase in peak volume of oxygen consumption. At 6-month follow-up, the exercise responder rate was significantly higher in EECP patients compared with controls (P=.008). Further, in contrast to the overall PEECH study, the EECP group demonstrated a significantly higher responder rate for peak oxygen consumption (P=.017). The authors conclude that an older subgroup of PEECH subjects confirms the beneficial effect of EECP in patients with chronic, stable, mild-to-moderate heart failure.

增強體外反搏可改善老年心臟衰患者的 運動持續時間 和峰值耗氧量:PEECH 試驗的分組分析」

此論文表明,體外反搏治療(EECP)能增加 運動持續時間 ,改善功能狀態和生活質量,而不影響峰值氧氣消耗量。該研究的作者提供了與體外反搏治療慢性心臟衰竭的前瞻性評估(PEECH)中預先指定的老年患者(65歲或以上)的亞組數據。該研究的兩個主要終點是 運動持續時間 增加60秒以上的受試者百分比,和峰值氧氣消耗量增加1.25毫升/千克/分以上的受試者百分比。在6個月的隨訪中,EECP組的運動反應者比例顯著高於對照組。此外,與PEECH的整體研究結果相反,EECP組的峰值氧氣消耗量反應者比例顯著更高。作者得出結論,PEECH試驗中的老年亞組證實了EECP在慢性穩定輕至中度心臟衰竭患者中的有益效果。

×